Gates Foundation Partners With Indian Drugmakers to Speed Rollout of $40 HIV Shot

A twice-yearly injection described as the most promising HIV prevention tool in decades is poised to reach millions more people, with new generic versions priced at about $40 per patient per year....

Redirecting to full article...